Aurobindo Pharma sinks 8%, stock hits over 3-month low post Q3 results (Soban News)

Aurobindo Pharma stock outlook: Eugia III resolution (in the backdrop of fresh observations) and the launch momentum across geographies would be key determinants, say analysts.​Aurobindo Pharma stock outlook: Eugia III resolution (in the backdrop of fresh observations) and the launch momentum across geographies would be key determinants, say analysts. ​Latest News [ SOBAN NEWS: International and National ]